193 related articles for article (PubMed ID: 3136650)
21. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
[No Abstract] [Full Text] [Related]
22. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Weissman A; Loumaye E; Shoham Z
Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
[TBL] [Abstract][Full Text] [Related]
23. Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH.
Fleming R; Hamilton MP; Conaghan C; Black WP; Coutts JR
Clin Endocrinol (Oxf); 1990 Jan; 32(1):33-8. PubMed ID: 2110046
[TBL] [Abstract][Full Text] [Related]
24. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
[TBL] [Abstract][Full Text] [Related]
25. Plasma estrogen monitoring of ovulation induction.
Wu CH
Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
[TBL] [Abstract][Full Text] [Related]
26. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
[TBL] [Abstract][Full Text] [Related]
27. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist.
Gadir AA; Alnaser HM; Mowafi RS; Shaw RW
Fertil Steril; 1992 Feb; 57(2):309-13. PubMed ID: 1735480
[TBL] [Abstract][Full Text] [Related]
28. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.
Emperaire JC; Ruffie A
Hum Reprod; 1991 Apr; 6(4):506-10. PubMed ID: 1918298
[TBL] [Abstract][Full Text] [Related]
29. Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.
Buckler HM; Phillips SE; Cameron IT; Healy DL; Burger HG
J Clin Endocrinol Metab; 1988 Aug; 67(2):300-6. PubMed ID: 3134388
[TBL] [Abstract][Full Text] [Related]
30. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
Martin KA; Hall JE; Adams JM; Crowley WF
J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
[TBL] [Abstract][Full Text] [Related]
31. Endocrinology of female infertility.
Baird DT
Br Med Bull; 1979 May; 35(2):193-8. PubMed ID: 387167
[TBL] [Abstract][Full Text] [Related]
32. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression.
Fleming R; Coutts JR
Fertil Steril; 1986 Feb; 45(2):226-30. PubMed ID: 3081375
[TBL] [Abstract][Full Text] [Related]
33. The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.
Fleming R; Jamieson ME; Hamilton MP; Black WP; Macnaughton MC; Coutts JR
Acta Endocrinol Suppl (Copenh); 1988; 288():77-84. PubMed ID: 3138869
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
[TBL] [Abstract][Full Text] [Related]
35. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
36. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
[TBL] [Abstract][Full Text] [Related]
37. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.
Seibel MM; McArdle C; Smith D; Taymor ML
Fertil Steril; 1985 May; 43(5):703-8. PubMed ID: 3922800
[TBL] [Abstract][Full Text] [Related]
38. The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate.
Bachus KE; Hughes CL; Haney AF; Dodson WC
Fertil Steril; 1990 Jul; 54(1):27-31. PubMed ID: 2113488
[TBL] [Abstract][Full Text] [Related]
39. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
Saffan D; Seibel MM
Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy following induction of ovulation with pure FSH after suppression of endogenous gonadotropins with subcutaneous buserelin.
Albert PJ; Schläfke J; Kaesemann H; Gille J
Arch Gynecol Obstet; 1987; 241(1):53-6. PubMed ID: 3118825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
